Reverse Phase High Performance Liquid Chromatography Method for the Estimation of Mangiferin in Nano Formulations: Development and Optimization by Analytical Quality-by-Design. [PDF]
Kamath AP +4 more
europepmc +1 more source
Green UHPLC approach for the quantitative determination of tiopronin residues in cleaning validation processes. [PDF]
Gohel J, Patel A, Kotadiya R.
europepmc +1 more source
Comparative AI-optimized HPLC-DAD strategy for the simultaneous determination of ranolazine, amlodipine, and diltiazem with pharmacotherapeutic relevance and multi-trait sustainability assessment. [PDF]
Aboras SI +3 more
europepmc +1 more source
The pharmaceutical sector is witnessing a fundamental transition from empirical "One- Factor-At-A-Time" (OFAT) methodologies toward the highly structured "Analytical Quality by Design" (AQbD) paradigm. This review aims to critically evaluate how AQbD enhances the robustness and reliability of High-Performance Liquid Chromatography (HPLC) methods ...
openaire +1 more source
Implementation of the QbD Approach to the Analytical Method Development and Validation for the Estimation of the Treprostinil Injection Dosage Form by RP-HPLC. [PDF]
Alluri NR +3 more
europepmc +1 more source
Designing Quality: Quality by Design in the analytical pharmaceutical development. [PDF]
Nompari, Luca
core
Breakthrough RP-HPLC strategy for synchronous analysis of pyridine and its degradation products in powder for injection using quality metrics. [PDF]
Al-Wasidi AS +5 more
europepmc +1 more source
Analytical quality by design-based development of a capillary electrophoresis method for Omeprazole impurity profiling [PDF]
Furlanetto, S. +2 more
core +1 more source
RP-DAD-HPLC Method for Quantitative Analysis of Clofazimine and Pyrazinamide for Inclusion in Fixed-Dose Combination Topical Drug Delivery System. [PDF]
Brits M, Bouwer F, Viljoen JM.
europepmc +1 more source
The paradigm of pharmaceutical analysis is undergoing a critical transition from traditional empirical Quality by Testing (QbT) frameworks to systematic, risk-based methodologies encapsulated by the Analytical Quality by Design (AQbD) initiative. This shift is particularly crucial for Fixed-Dose Combinations (FDCs), where the simultaneous estimation of
openaire +1 more source

